Progress Towards Measles Elimination in Nigeria: 2012 - 2016.

Journal of immunological sciences Pub Date : 2018-08-02
Balcha Masresha, Fiona Braka, Nneka Ukachi Onwu, Joseph Oteri, Tesfaye Erbeto, Saliu Oladele, Kyandindi Sumaili, Abimbola Aman-Oloniyo, Regis Katsande, Sisay Gashu Tegegn, Amadou Fall
{"title":"Progress Towards Measles Elimination in Nigeria: 2012 - 2016.","authors":"Balcha Masresha, Fiona Braka, Nneka Ukachi Onwu, Joseph Oteri, Tesfaye Erbeto, Saliu Oladele, Kyandindi Sumaili, Abimbola Aman-Oloniyo, Regis Katsande, Sisay Gashu Tegegn, Amadou Fall","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Nigeria has adopted the African Regional measles elimination targets and is implementing the recommended strategies. Nigeria provides routine measles vaccination for children aged 9 months. In addition, since 2006, Nigeria has been conducting nationwide measles supplemental Immunisation activities (SIAs) or mass vaccination campaigns every 2 years, and has established measles case-based surveillance.</p><p><strong>Methods: </strong>We reviewed routine and supplemental measles immunization coverage data, as well as measles case-based surveillance data from Nigeria for the years 2012 - 2016, in an attempt to determine the country's progress towards these elimination targets.</p><p><strong>Results: </strong>The first dose measles vaccination coverage in Nigeria ranged from 42% and 54% between 2012 and 2015, according to the WHO UNICEF national coverage estimates. Nigeria achieved 84.5% coverage by survey following the 2015 nationwide measles supplemental immunisation activities (SIAs). During this period, the incidence of confirmed measles ranged from 25 - 300 confirmed cases per million population per year, with the Northern States having significantly higher incidence as compared to the Southern States. At the same time, the pattern of confirmed cases indicated a consistent shift in epidemiological susceptibility including older age children.</p><p><strong>Conclusions: </strong>In order to accelerate its progress towards the measles elimination targets, Nigeria should build population immunity on a sustainable basis by addressing systemic issues in order to scale up routine immunisation coverage, especially in the Northern half of the country; tailoring the target age for measles SIAs so as to sharply reduce measles incidence in age groups heavily affected by the disease; effectively mobilising resources and improving the quality of planning and coverage outcome of SIAs.</p>","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446991/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunological sciences","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Nigeria has adopted the African Regional measles elimination targets and is implementing the recommended strategies. Nigeria provides routine measles vaccination for children aged 9 months. In addition, since 2006, Nigeria has been conducting nationwide measles supplemental Immunisation activities (SIAs) or mass vaccination campaigns every 2 years, and has established measles case-based surveillance.

Methods: We reviewed routine and supplemental measles immunization coverage data, as well as measles case-based surveillance data from Nigeria for the years 2012 - 2016, in an attempt to determine the country's progress towards these elimination targets.

Results: The first dose measles vaccination coverage in Nigeria ranged from 42% and 54% between 2012 and 2015, according to the WHO UNICEF national coverage estimates. Nigeria achieved 84.5% coverage by survey following the 2015 nationwide measles supplemental immunisation activities (SIAs). During this period, the incidence of confirmed measles ranged from 25 - 300 confirmed cases per million population per year, with the Northern States having significantly higher incidence as compared to the Southern States. At the same time, the pattern of confirmed cases indicated a consistent shift in epidemiological susceptibility including older age children.

Conclusions: In order to accelerate its progress towards the measles elimination targets, Nigeria should build population immunity on a sustainable basis by addressing systemic issues in order to scale up routine immunisation coverage, especially in the Northern half of the country; tailoring the target age for measles SIAs so as to sharply reduce measles incidence in age groups heavily affected by the disease; effectively mobilising resources and improving the quality of planning and coverage outcome of SIAs.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
尼日利亚在消除麻疹方面取得的进展:2012 - 2016.
导言:尼日利亚采纳了非洲地区消除麻疹的目标,并正在实施建议的战略。尼日利亚为 9 个月大的儿童提供常规麻疹疫苗接种。此外,自 2006 年起,尼日利亚每两年在全国范围内开展一次麻疹补充免疫活动或大规模疫苗接种活动,并建立了麻疹病例监测机制:我们审查了尼日利亚 2012 年至 2016 年的常规和补充麻疹免疫接种覆盖率数据以及麻疹病例监测数据,以确定该国在实现这些消除目标方面取得的进展:根据世卫组织和联合国儿童基金会的全国覆盖率估计,2012 年至 2015 年间,尼日利亚的麻疹疫苗首剂接种率在 42% 和 54% 之间。在 2015 年全国范围的麻疹补充免疫活动 (SIA) 之后,尼日利亚的调查覆盖率达到了 84.5%。在此期间,每年每百万人口中麻疹确诊病例的发病率在 25 - 300 例之间,北部各州的发病率明显高于南部各州。同时,确诊病例的模式表明,包括大龄儿童在内的流行病易感人群在不断变化:为了加快实现消除麻疹的目标,尼日利亚应在可持续的基础上增强人口免疫力,解决系统性问题,以扩大常规免疫覆盖范围,尤其是在尼日利亚北部地区;调整麻疹 SIA 的目标年龄,以大幅降低受麻疹严重影响的年龄组的发病率;有效调动资源,提高 SIA 的规划质量和覆盖结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Commentary: Early-in-life Isoflurane Exposure Alters Resting-State Functional Connectivity in Juvenile Non-human Primates - a Role for Neuroinflammation? Community Involvement in Response to Ebola Virus Disease Epidemic in North Kivu and Ituri, Democratic Republic of Congo: A Mixed-Methods Study. Epidemic Response amidst Insecurity: Addressing the Ebola Virus Epidemic in the Provinces of North Kivu and Ituri. Exploring Alternative Care Platforms for Symptomatic People in the Fight against the Ebola Virus Disease Outbreak. Perceptions and Rumors About the Ebola Virus Disease Vaccine in the Ituri and Kivu Provinces of the Democratic Republic of Congo.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1